Wondering why some of your Pharma shares keep going up? Thank Trump’s tax “reform;” no, really.

The News: The drug industry has taken heat from patient advocates and a US senator for handing out its tax savings to shareholders instead of using its windfall to help patients… Read more »

AI continues creeping into the clinic as it diagnoses skin cancer better than expert dermatologists, new research shows. What’s next?

The News: Skin cancer was found to be diagnosed more accurately by artificial intelligence than experienced dermatologists in a new international study. Researchers tested a form of machine learning known as a deep… Read more »

Update: Where does Brexit leave European pharma, now that the EU has excluded the UK from drug approvals?

A European decision to exclude Britain from the EU’s drug approval system from beginning 30, 2019–the day after Brexit–has raised alarm among drugmakers, who fear the abrupt change could disrupt… Read more »

2018 biotech IPOs still on a tear, with 25 already priced; 8 new filings last week alone.

In all my 26 years at MondayMorning, never have I witnessed such a massive, mad dash for the IPO filing window, and the SEC must be wondering if and when… Read more »

Elizabeth Holmes’ partner in blood-fraud scheme largely anonymous. Theranos–the Movie–already in the works.

The News: Theranos, the humiliated, disintegrating, and allegedly fraud- packed blood-testing startup, is most often related to its founder and CEO, Elizabeth Holmes. But during the rise and fall of… Read more »

Who gets the best health care in America? You’re wrong; it’s prisoners. Times are a changing, as prison facilities morph into healthcare facilities.

The News: Jeffrey E. Keller, MD, FACEP, is a board-certified emergency physician with 25 years of experience before moving full time into his “true calling” of correctional medicine. In a… Read more »

Weekly Medical Stock Spotlight: Group still outperforming other sectors. My take.

All three major US stock indices posted a weekly loss last week as the markets reacted to reports from the US-China trade summit, rising US government bond yields and increasing… Read more »